Tyra Biosciences (TYRA) Share-based Compensation (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Share-based Compensation data on file, last reported at $74.4 million in Q1 2026.

• Quarterly Share-based Compensation rose 1910.81% year-over-year to $74.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.4 million (up 232.35% YoY) and the FY2025 annual result came in at $75.8 million, up 16.44% from the prior year.
• Share-based Compensation grew to $74.4 million in Q1 2026, from $7.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $74.4 million in Q1 2026 to a low of $16000.0 in Q4 2022.
• A 5-year average of $9.6 million and a median of $4.4 million in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation plunged 99.03% — and 2023, when it surged 26062.5%.
• Tracing TYRA's Share-based Compensation over 5 years: stood at $16000.0 in 2022, then surged by 26062.5% to $4.2 million in 2023, then jumped by 60.11% to $6.7 million in 2024, then climbed by 13.8% to $7.6 million in 2025, then jumped by 875.48% to $74.4 million in 2026.
• The last three Share-based Compensation figures came in at $74.4 million (Q1 2026), $7.6 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.